Breaking the Resistance: The Molecular Impact of $\beta$-Glucans on Hepatocellular Carcinoma (HCC)

The Clinical Challenge Hepatocellular Carcinoma (HCC) remains one of the most challenging malignancies due to its high rate of recurrence and the rapid development of resistance to multi-kinase inhibitors like Sorafenib. In the U.S. oncology landscape, the search for non-toxic…



